{"symbol":"SZ002262","secucode":"002262.SZ","items":[{"title":"上海国投先导、恩华药业等在上海成立创投基金","summary":"企查查APP显示，近日，上海德福创业投资基金合伙企业（有限合伙）成立，出资额约2.17亿元，经营范围包含：创业投资（限投资未上市企业）。企查查股权穿透显示，该合伙企业由上海国投先导生物医药私募投资基金合伙企业（有限合伙）、恩华药业、百利天恒（上海）生物医药科技有限责任公司等共同持股。","source":null,"url":"http://finance.eastmoney.com/news/1354,202608063833636895.html","info_code":"NW202608063833636895","show_time_timestamp":1785983580000,"show_time":"2026-08-06 10:33:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202608063833636895.html","url":"http://finance.eastmoney.com/news/1354,202608063833636895.html","code":"202608063833636895","infoCode":"NW202608063833636895","recordId":null,"source":null,"title":"上海国投先导、恩华药业等在上海成立创投基金","updateTime":0,"showDateTime":1785983580000,"publishDate":0,"sRatingName":null,"summary":"企查查APP显示，近日，上海德福创业投资基金合伙企业（有限合伙）成立，出资额约2.17亿元，经营范围包含：创业投资（限投资未上市企业）。企查查股权穿透显示，该合伙企业由上海国投先导生物医药私募投资基金合伙企业（有限合伙）、恩华药业、百利天恒（上海）生物医药科技有限责任公司等共同持股。"}},{"title":"芬太尼概念涨1.36%，主力资金净流入3股","summary":"截至7月30日收盘，芬太尼概念上涨1.36%，位居概念板块涨幅第3，板块内，8股上涨，博拓生物、万孚生物、国药现代等涨幅居前，分别上涨3.62%、2.13%、1.61%。","source":null,"url":"http://finance.eastmoney.com/news/1354,202607303826815670.html","info_code":"NW202607303826815670","show_time_timestamp":1785404700000,"show_time":"2026-07-30 17:45:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202607303826815670.html","url":"http://finance.eastmoney.com/news/1354,202607303826815670.html","code":"202607303826815670","infoCode":"NW202607303826815670","recordId":null,"source":null,"title":"芬太尼概念涨1.36%，主力资金净流入3股","updateTime":0,"showDateTime":1785404700000,"publishDate":0,"sRatingName":null,"summary":"截至7月30日收盘，芬太尼概念上涨1.36%，位居概念板块涨幅第3，板块内，8股上涨，博拓生物、万孚生物、国药现代等涨幅居前，分别上涨3.62%、2.13%、1.61%。"}},{"title":"恩华药业：公司创新药NH600001处于CDE正常审核之中","summary":"证券日报网讯7月22日，恩华药业在互动平台回答投资者提问时表示，公司创新药NH600001处于CDE正常审核之中，各项相关工作在有序顺利进行。获得该创新药上市批件后，公司会及时进行公告。","source":null,"url":"http://finance.eastmoney.com/news/1354,202607223817545639.html","info_code":"NW202607223817545639","show_time_timestamp":1784723340000,"show_time":"2026-07-22 20:29:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202607223817545639.html","url":"http://finance.eastmoney.com/news/1354,202607223817545639.html","code":"202607223817545639","infoCode":"NW202607223817545639","recordId":null,"source":null,"title":"恩华药业：公司创新药NH600001处于CDE正常审核之中","updateTime":0,"showDateTime":1784723340000,"publishDate":0,"sRatingName":null,"summary":"证券日报网讯7月22日，恩华药业在互动平台回答投资者提问时表示，公司创新药NH600001处于CDE正常审核之中，各项相关工作在有序顺利进行。获得该创新药上市批件后，公司会及时进行公告。"}},{"title":"恩华药业：关于与专业投资机构共同投资设立私募基金进展暨工商登记完成的公告","summary":"证券日报网讯7月21日，恩华药业发布公告称，公司参与设立的上海德福创业投资基金合伙企业（有限合伙）已完成工商登记，取得营业执照。该基金由公司作为有限合伙人出资2000万元，占目标认缴规模80000万元的2.50%。","source":null,"url":"http://finance.eastmoney.com/news/1354,202607213815743623.html","info_code":"NW202607213815743623","show_time_timestamp":1784629800000,"show_time":"2026-07-21 18:30:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202607213815743623.html","url":"http://finance.eastmoney.com/news/1354,202607213815743623.html","code":"202607213815743623","infoCode":"NW202607213815743623","recordId":null,"source":null,"title":"恩华药业：关于与专业投资机构共同投资设立私募基金进展暨工商登记完成的公告","updateTime":0,"showDateTime":1784629800000,"publishDate":0,"sRatingName":null,"summary":"证券日报网讯7月21日，恩华药业发布公告称，公司参与设立的上海德福创业投资基金合伙企业（有限合伙）已完成工商登记，取得营业执照。该基金由公司作为有限合伙人出资2000万元，占目标认缴规模80000万元的2.50%。"}},{"title":"芬太尼概念下跌1.85%，主力资金净流出5股","summary":"截至7月21日收盘，芬太尼概念下跌1.85%，位居概念板块跌幅榜前列，板块内，博拓生物、东方生物、国药现代等跌幅居前。","source":null,"url":"http://stock.eastmoney.com/news/11791,202607213815600738.html","info_code":"NW202607213815600738","show_time_timestamp":1784623740000,"show_time":"2026-07-21 16:49:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202607213815600738.html","url":"http://stock.eastmoney.com/news/11791,202607213815600738.html","code":"202607213815600738","infoCode":"NW202607213815600738","recordId":null,"source":null,"title":"芬太尼概念下跌1.85%，主力资金净流出5股","updateTime":0,"showDateTime":1784623740000,"publishDate":0,"sRatingName":null,"summary":"截至7月21日收盘，芬太尼概念下跌1.85%，位居概念板块跌幅榜前列，板块内，博拓生物、东方生物、国药现代等跌幅居前。"}}]}